Blocking AMPKαS496 phosphorylation improves mitochondrial dynamics and hyperglycemia in aging and obesity
Cell Chemical Biology · 2023
DOI: 10.1016/j.chembiol.2023.09.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Chemical Biology, 2023. Verfasst von Alexia Pearah und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Hyperglycemia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIGMS NIH HHS, Johns Hopkins University.
Abstract (Originalsprache)
Impaired mitochondrial dynamics causes aging-related or metabolic diseases. Yet, the molecular mechanism responsible for the impairment of mitochondrial dynamics is still not well understood. Here, we report that elevated blood insulin and/or glucagon levels downregulate mitochondrial fission through directly phosphorylating AMPKα at S496 by AKT or PKA, resulting in the impairment of AMPK-MFF-DRP1 signaling and mitochondrial dynamics and activity. Since there are significantly increased AMPKα1 phosphorylation at S496 in the liver of elderly mice, obese mice, and obese patients, we, therefore, designed AMPK-specific targeting peptides (Pa496m and Pa496h) to block AMPKα1S496 phosphorylation and found that these targeting peptides can increase AMPK kinase activity, augment mitochondrial fission and oxidation, and reduce ROS, leading to the rejuvenation of mitochondria. Furthermore, these AMPK targeting peptides robustly suppress liver glucose production in obese mice. Our data suggest these targeting peptides are promising therapeutic agents for improving mitochondrial dynamics and activity and alleviating hyperglycemia in elderly and obese patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Departments of Pediatrics and Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA.
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA; Departments of Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.…
Förderung
- NIDDK NIH HHS
- NIGMS NIH HHS
- Johns Hopkins University
- NIH
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Pearah, A., Ramatchandirin, B., Liu, T., Wolf, R. M., Ikeda, A., Radovick, S., Sesaki, H., Wondisford, F. E., O'Rourke, B., & He, L. (2023). Blocking AMPKαS496 phosphorylation improves mitochondrial dynamics and hyperglycemia in aging and obesity. Cell Chemical Biology. https://doi.org/10.1016/j.chembiol.2023.09.017
Vancouver
Pearah A, Ramatchandirin B, Liu T, Wolf RM, Ikeda A, Radovick S, et al. Blocking AMPKαS496 phosphorylation improves mitochondrial dynamics and hyperglycemia in aging and obesity. Cell Chemical Biology. 2023. doi:10.1016/j.chembiol.2023.09.017
BibTeX
@article{Pearah2023,
author = {Pearah, Alexia and Ramatchandirin, Balamurugan and Liu, Ting and Wolf, Risa M and Ikeda, Arisa and Radovick, Sally and Sesaki, Hiromi and Wondisford, Fredric E and O'Rourke, Brian and He, Ling},
title = {Blocking AMPKαS496 phosphorylation improves mitochondrial dynamics and hyperglycemia in aging and obesity},
journal = {Cell Chemical Biology},
year = {2023},
doi = {10.1016/j.chembiol.2023.09.017}
}
EUVIMED